W
William M. Wara
Researcher at Kaiser Permanente
Publications - 236
Citations - 19857
William M. Wara is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Radiation therapy & Survival rate. The author has an hindex of 81, co-authored 236 publications receiving 19307 citations. Previous affiliations of William M. Wara include University of California & Harvard University.
Papers
More filters
Journal ArticleDOI
Therapeutic irradiation and brain injury.
TL;DR: Eighty cases were identified in which the patient was given a single course of radiation therapy and in which reasonable estimates of the time-dose-fractionation regimen could be made, and total dose, overall treatment time and number of treatment fractions were analyzed.
Journal ArticleDOI
Postoperative irradiation for subtotally resected meningiomas: A retrospective analysis of 140 patients treated from 1967 to 1990
TL;DR: Evaluated patients treated at the University of California, San Francisco, from 1967 to 1990 found subtotal resection combined with precise treatment planning techniques and adjuvant radiation therapy can achieve results comparable to those of total resection.
Journal ArticleDOI
Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study
Roger J. Packer,Joel W. Goldwein,H. Stacy Nicholson,L. Gilbert Vezina,Jeffrey C. Allen,M. Douglas Ris,Karin M. Muraszko,Lucy B. Rorke,William M. Wara,Bruce H. Cohen,James M. Boyett +10 more
TL;DR: The results suggest that reduced-dose craniospinal radiation therapy and adjuvant chemotherapy during and after radiation is a feasible approach for children with nondisseminated medulloblastoma.
Journal ArticleDOI
The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone
Audrey E. Evans,R. Derek T. Jenkin,Richard Sposto,Jorge A. Ortega,Charles Wilson,William M. Wara,Inta J. Ertel,Simon Kramer,Chu H. Chang,Sanford L. Leikin,G. Denman Hammond +10 more
TL;DR: It is concluded that chemotherapy does not benefit patients with low-stage medulloblastoma, but may benefit those with more advanced stages of disease.
Journal ArticleDOI
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Penny K. Sneed,Paul R. Stauffer,Michael W. McDermott,Chris J. Diederich,Kathleen R. Lamborn,Michael D. Prados,Susan M. Chang,Keith A. Weaver,Laura Spry,Mary Malec,Sharon Lamb,Brigid Voss,Richard L. Davis,William M. Wara,David A. Larson,Theodore L. Phillips,Philip H. Gutin +16 more
TL;DR: Adjuvant interstitial brain HT, given before and after brachytherapy boost, after conventional radiotherapy significantly improves survival of patients with focal glioblastoma, with acceptable toxicity.